Correlation Between NYSE Composite and Humacyte
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Humacyte, you can compare the effects of market volatilities on NYSE Composite and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Humacyte.
Diversification Opportunities for NYSE Composite and Humacyte
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between NYSE and Humacyte is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of NYSE Composite i.e., NYSE Composite and Humacyte go up and down completely randomly.
Pair Corralation between NYSE Composite and Humacyte
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.12 times more return on investment than Humacyte. However, NYSE Composite is 8.16 times less risky than Humacyte. It trades about 0.42 of its potential returns per unit of risk. Humacyte is currently generating about -0.23 per unit of risk. If you would invest 1,923,895 in NYSE Composite on September 1, 2024 and sell it today you would earn a total of 103,309 from holding NYSE Composite or generate 5.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Humacyte
Performance |
| Timeline |
NYSE Composite and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Humacyte
Pair trading matchups for Humacyte
Pair Trading with NYSE Composite and Humacyte
The main advantage of trading using opposite NYSE Composite and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| NYSE Composite vs. Acumen Pharmaceuticals | NYSE Composite vs. Mind Medicine | NYSE Composite vs. NL Industries | NYSE Composite vs. Ecovyst |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |